Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil - Treiber, A; Schneiter, R; Häusler, S; Stieger, B (Drug MetabDispos, 2007)